NO964915D0 - Transdermal avlevering av antiepileptiske legemidler - Google Patents
Transdermal avlevering av antiepileptiske legemidlerInfo
- Publication number
- NO964915D0 NO964915D0 NO964915A NO964915A NO964915D0 NO 964915 D0 NO964915 D0 NO 964915D0 NO 964915 A NO964915 A NO 964915A NO 964915 A NO964915 A NO 964915A NO 964915 D0 NO964915 D0 NO 964915D0
- Authority
- NO
- Norway
- Prior art keywords
- transdermal delivery
- antiepileptic drugs
- antiepileptic
- drugs
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK57794 | 1994-05-20 | ||
| PCT/DK1995/000194 WO1995031976A1 (en) | 1994-05-20 | 1995-05-17 | Transdermal delivery of anti-epileptic drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO964915L NO964915L (no) | 1996-11-19 |
| NO964915D0 true NO964915D0 (no) | 1996-11-19 |
Family
ID=8095138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964915A NO964915D0 (no) | 1994-05-20 | 1996-11-19 | Transdermal avlevering av antiepileptiske legemidler |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5750140A (no) |
| EP (1) | EP0760656A1 (no) |
| JP (1) | JPH10500415A (no) |
| KR (1) | KR970703146A (no) |
| CN (1) | CN1148806A (no) |
| AU (1) | AU698131B2 (no) |
| BR (1) | BR9507736A (no) |
| CA (1) | CA2190837C (no) |
| CZ (1) | CZ338196A3 (no) |
| FI (1) | FI964619A0 (no) |
| HU (1) | HUT75864A (no) |
| IL (1) | IL113793A (no) |
| NO (1) | NO964915D0 (no) |
| NZ (1) | NZ287012A (no) |
| PE (1) | PE2596A1 (no) |
| RU (1) | RU2152784C1 (no) |
| SK (1) | SK281076B6 (no) |
| TW (1) | TW372875B (no) |
| WO (1) | WO1995031976A1 (no) |
| ZA (1) | ZA954118B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA52661C2 (uk) * | 1996-06-14 | 2003-01-15 | Ново Нордіск А/С | Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти |
| US5914333A (en) * | 1996-07-31 | 1999-06-22 | Novo Nordisk A/S | Treatment of psychotic disorders |
| US6537537B2 (en) | 1997-06-12 | 2003-03-25 | The Procter & Gamble Company | Water-in-silicone emulsion cosmetic compositions |
| GB9712269D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
| GB9712271D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
| US6316010B2 (en) | 1997-06-12 | 2001-11-13 | The Procter & Gamble Company | Cosmetic compositions |
| GB9712272D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
| DK0991409T3 (da) * | 1997-08-01 | 2002-03-25 | Elan Corp Plc | Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse |
| IE970588A1 (en) | 1997-08-01 | 2000-08-23 | Elan Corp Plc | Controlled release pharmaceutical compositions containing tiagabine |
| FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
| CA2479672A1 (en) * | 2002-03-18 | 2003-10-02 | Roger K. Cady | Preemptive prophylaxis of migraine |
| MX2020001525A (es) | 2017-08-24 | 2020-03-20 | Novo Nordisk As | Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos. |
| IL294521A (en) | 2020-02-18 | 2022-09-01 | Novo Nordisk As | glp-1 compounds and their uses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105990B (en) * | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
| DK288385D0 (da) * | 1985-06-26 | 1985-06-26 | Novo Industri As | Aminosyrederivater |
| SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
| DK58291D0 (da) * | 1991-04-02 | 1991-04-02 | Novo Nordisk As | Krystalinsk stof og dets fremstilling |
-
1995
- 1995-05-12 US US08/440,155 patent/US5750140A/en not_active Expired - Lifetime
- 1995-05-17 AU AU25599/95A patent/AU698131B2/en not_active Ceased
- 1995-05-17 CZ CZ963381A patent/CZ338196A3/cs unknown
- 1995-05-17 EP EP95919972A patent/EP0760656A1/en active Pending
- 1995-05-17 CN CN95193165A patent/CN1148806A/zh active Pending
- 1995-05-17 CA CA002190837A patent/CA2190837C/en not_active Expired - Fee Related
- 1995-05-17 RU RU96124084/14A patent/RU2152784C1/ru active
- 1995-05-17 BR BR9507736A patent/BR9507736A/pt not_active IP Right Cessation
- 1995-05-17 SK SK1482-96A patent/SK281076B6/sk unknown
- 1995-05-17 WO PCT/DK1995/000194 patent/WO1995031976A1/en not_active Ceased
- 1995-05-17 HU HU9603206A patent/HUT75864A/hu unknown
- 1995-05-17 FI FI964619A patent/FI964619A0/fi unknown
- 1995-05-17 JP JP7529988A patent/JPH10500415A/ja active Pending
- 1995-05-17 NZ NZ287012A patent/NZ287012A/en unknown
- 1995-05-19 PE PE1995269113A patent/PE2596A1/es not_active Application Discontinuation
- 1995-05-19 IL IL11379395A patent/IL113793A/xx not_active IP Right Cessation
- 1995-05-19 ZA ZA954118A patent/ZA954118B/xx unknown
- 1995-05-26 TW TW084105009A patent/TW372875B/zh active
-
1996
- 1996-11-19 NO NO964915A patent/NO964915D0/no not_active Application Discontinuation
- 1996-11-20 KR KR1019960706589A patent/KR970703146A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HUT75864A (en) | 1997-05-28 |
| CA2190837C (en) | 2005-08-02 |
| AU698131B2 (en) | 1998-10-22 |
| FI964619L (fi) | 1996-11-19 |
| CZ338196A3 (en) | 1997-06-11 |
| KR970703146A (ko) | 1997-07-03 |
| IL113793A0 (en) | 1995-08-31 |
| JPH10500415A (ja) | 1998-01-13 |
| EP0760656A1 (en) | 1997-03-12 |
| NO964915L (no) | 1996-11-19 |
| TW372875B (en) | 1999-11-01 |
| US5750140A (en) | 1998-05-12 |
| ZA954118B (en) | 1996-11-19 |
| RU2152784C1 (ru) | 2000-07-20 |
| FI964619A7 (fi) | 1996-11-19 |
| NZ287012A (en) | 1998-09-24 |
| CN1148806A (zh) | 1997-04-30 |
| CA2190837A1 (en) | 1995-11-30 |
| HU9603206D0 (en) | 1997-01-28 |
| SK281076B6 (sk) | 2000-11-07 |
| BR9507736A (pt) | 1997-08-19 |
| WO1995031976A1 (en) | 1995-11-30 |
| FI964619A0 (fi) | 1996-11-19 |
| SK148296A3 (en) | 1997-06-04 |
| PE2596A1 (es) | 1996-02-12 |
| IL113793A (en) | 1999-12-31 |
| AU2559995A (en) | 1995-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69938299D1 (de) | Lokale abgabe von arzneimitteln | |
| NO963990D0 (no) | To-komponentanordning for tilförsel av medikamenter | |
| FI972292A0 (fi) | Administrering av diabetes | |
| MA26549A1 (fr) | Medicaments | |
| FI973243A0 (fi) | Uusi farmaseuttinen yhdistelmä | |
| EE9700241A (et) | Farmatseutiline kompositsioon transdermaalseks manustamiseks | |
| FI971279A0 (fi) | Lääkkeitä | |
| DK0754061T3 (da) | Ny oral farmaceutisk doseringsform | |
| DE69634053D1 (de) | Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin | |
| EE9800025A (et) | Transkorneaalne süsteem ravimite manustamiseks | |
| KR950703383A (ko) | 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system) | |
| FR2767121B1 (fr) | Distributeur de medicaments | |
| NO962231L (no) | Prolegemidler av paclitaxelderivater | |
| NO964915D0 (no) | Transdermal avlevering av antiepileptiske legemidler | |
| EP0850057A4 (en) | Pharmaceutical compounds | |
| FI960887A7 (fi) | Antimigreenilääkkeen iontoforeettinen kuljetus | |
| FI950389A0 (fi) | Ny medicinsk anvaendning av hemiprodukter | |
| FI970053A7 (fi) | Transdermaalinen lääkeaineen antosysteemi | |
| SE9400861D0 (sv) | Halvfast beredningsform för läkemedel | |
| DE69634569D1 (de) | Medikamentenabgabevorrichtung | |
| BR9612652A (pt) | Forma de administração farmacêutica | |
| FI960435A0 (fi) | Lääkkeiden transdermaalisen antotapaan tarkoitettuLääkkeiden transdermaalisen antotapaan tarkoitettu koostumus koostumus | |
| UA25519A (uk) | Спосіб іhтракаротидhого введеhhя лікарських препаратів | |
| SE9401674L (sv) | Läkemedel | |
| NO944330D0 (no) | Legemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |